Dr. Jivan Lamichhane, MD

Dr. Lamichhane practices at Upstate University Hospital in Syracuse, New York, part of State University of New York.

Dr. Lamichhane's NPI, 1326267949, was assigned on April 24, 2007. Dr. Lamichhane graduated from Nepal Medical College in 2003. Dr. Lamichhane holds New York license 261468.

Dr. Lamichhane's primary practice is Upstate University Hospital, at 750 East Adams Street, Syracuse, NY 13210 in Onondaga County. The practice phone is (315) 473-4240.

Dr. Lamichhane's primary practice is Upstate University Hospital in Syracuse, New York, part of State University of New York. The medical group on file is Department of Medicine. Dmand AI also links Dr. Lamichhane to 1 more therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lamichhane practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Lamichhane's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Lamichhane is licensed in New York.

CMS data shows 591 Medicare services from Dr. Lamichhane across 4 procedure codes in 2024, for 186 Medicare patients. Medicare paid $34,827 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 186 Medicare patients who saw Dr. Lamichhane in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lamichhane's median patient age at 65, with 47% women.

In 2024, Dr. Lamichhane wrote 134 Medicare Part D claims for 67 patients. 87% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $29 in total drug cost. In 2017, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Lamichhane for performance year 2024, reported as part of a group. Dr. Lamichhane accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Lamichhane from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $49.

Dr. Lamichhane graduated from Nepal Medical College in 2003.